Viatris (VTRS) Financial Analysis & Valuation | Quarter Chart
Viatris (VTRS)
VTRSPrice: $13.61
Fair Value: 🔒
🔒score
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The compa... more
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Deve... more
Description
Shares
| Market Cap | $15.67B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Country | US | CEO | Scott Andrew Smith |
| IPO Date | 1980-03-17 | CAGR | 0.13% |
| Employees | 32,000 | Website | www.viatris.com |
| Div. Yield | 0.01% | Payout Ratio | -0.15% |
| Buy Back Yield | 0.01% | Total Yield | 0.02% |
VTRS chart loading...
Fundamentals
Technicals
| Enterprise Value | $30.76B | P/E Ratio | -4.54 |
| Forward P/E | 5.1 | PEG Ratio | — |
| P/S Ratio | 440974684845.48 | P/B Ratio | 417999649788.11 |
| P/CF Ratio | 3171353036618.87 | P/FCF Ratio | 3828778794294.22 |
| EPS | $-3 | EPS Growth 1Y | 319.91% |
| EPS Growth 3Y | -568.77% | EPS Growth 5Y | -699.71% |
| Revenue Growth 1Y | -6.14% | Gross Margin | 0.36% |
| Operating Margin | -0.19% | Profit Margin | -0.26% |
| ROE | -0.23% | ROA | -0.1% |
| ROCE | -0.09% | Current Ratio | 1.35 |
| Quick Ratio | 0.79 | Cash Ratio | 0.13 |
| Debt/Equity | 1.07 | Interest Coverage | -5.62 |
| Altman Z Score | 0.58 | Piotroski Score | 5 |